Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gan, Chun Loo
  • Dudani, Shaan
  • Wells, Connor
  • Donskov, Frede
  • Pal, Sumanta K
  • Dizman, Nazli
  • Rathi, Nityam
  • Beuselinck, Benoit
  • Yan, Flora
  • Lalani, Aly-Khan
  • Hansen, Aaron Richard
  • Szabados, Bernadett
  • de Velasco, Guillermo
  • Tran, Ben
  • Lee, Jae-Lyun
  • Vaishampayan, Ulka N
  • Bjarnason, Georg A
  • Subasri, Mathushan
  • Choueiri, Toni K
  • Heng, Daniel Yick Chin

publication date

  • February 20, 2020